

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 4.51050812 |
| 2 | behavioral response to nicotine (GO:0035095) | 4.34906085 |
| 3 | fucose catabolic process (GO:0019317) | 4.07169823 |
| 4 | L-fucose metabolic process (GO:0042354) | 4.07169823 |
| 5 | L-fucose catabolic process (GO:0042355) | 4.07169823 |
| 6 | indolalkylamine metabolic process (GO:0006586) | 3.89060213 |
| 7 | neural tube formation (GO:0001841) | 3.70502649 |
| 8 | tryptophan catabolic process (GO:0006569) | 3.65175530 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 3.65175530 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 3.65175530 |
| 11 | response to pheromone (GO:0019236) | 3.61275744 |
| 12 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.51914527 |
| 13 | protein K11-linked deubiquitination (GO:0035871) | 3.47158282 |
| 14 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.35149820 |
| 15 | detection of light stimulus involved in visual perception (GO:0050908) | 3.35149820 |
| 16 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.34343829 |
| 17 | tryptophan metabolic process (GO:0006568) | 3.26465774 |
| 18 | axoneme assembly (GO:0035082) | 3.19682455 |
| 19 | sulfation (GO:0051923) | 3.19505514 |
| 20 | kynurenine metabolic process (GO:0070189) | 3.16882647 |
| 21 | cellular ketone body metabolic process (GO:0046950) | 3.13706248 |
| 22 | cytidine metabolic process (GO:0046087) | 3.05394816 |
| 23 | cytidine catabolic process (GO:0006216) | 3.05394816 |
| 24 | cytidine deamination (GO:0009972) | 3.05394816 |
| 25 | negative regulation of mast cell activation (GO:0033004) | 3.04381134 |
| 26 | establishment of protein localization to Golgi (GO:0072600) | 3.02032254 |
| 27 | dopamine transport (GO:0015872) | 2.97936355 |
| 28 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.95406289 |
| 29 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.88512882 |
| 30 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.86223322 |
| 31 | signal peptide processing (GO:0006465) | 2.85625841 |
| 32 | ketone body metabolic process (GO:1902224) | 2.84736085 |
| 33 | reflex (GO:0060004) | 2.83984410 |
| 34 | epithelial cilium movement (GO:0003351) | 2.83860932 |
| 35 | indole-containing compound metabolic process (GO:0042430) | 2.83614902 |
| 36 | piRNA metabolic process (GO:0034587) | 2.79410776 |
| 37 | behavioral response to ethanol (GO:0048149) | 2.75172453 |
| 38 | kidney morphogenesis (GO:0060993) | 2.74782137 |
| 39 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.73403148 |
| 40 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.69419929 |
| 41 | activated T cell proliferation (GO:0050798) | 2.67416258 |
| 42 | photoreceptor cell maintenance (GO:0045494) | 2.66361075 |
| 43 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.66302205 |
| 44 | platelet dense granule organization (GO:0060155) | 2.63925902 |
| 45 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.63686987 |
| 46 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.63686987 |
| 47 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.63686987 |
| 48 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.63237992 |
| 49 | cellular biogenic amine catabolic process (GO:0042402) | 2.63056873 |
| 50 | amine catabolic process (GO:0009310) | 2.63056873 |
| 51 | cAMP catabolic process (GO:0006198) | 2.62976401 |
| 52 | regulation of memory T cell differentiation (GO:0043380) | 2.62767084 |
| 53 | cellular response to interleukin-15 (GO:0071350) | 2.60642583 |
| 54 | adaptation of signaling pathway (GO:0023058) | 2.59660994 |
| 55 | serotonin metabolic process (GO:0042428) | 2.59592688 |
| 56 | primary amino compound metabolic process (GO:1901160) | 2.58383747 |
| 57 | multicellular organism reproduction (GO:0032504) | 2.55697004 |
| 58 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.55106196 |
| 59 | cilium movement (GO:0003341) | 2.55061725 |
| 60 | interferon-gamma production (GO:0032609) | 2.50208822 |
| 61 | positive regulation of defense response to virus by host (GO:0002230) | 2.49683402 |
| 62 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.49120850 |
| 63 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.48512481 |
| 64 | DNA methylation involved in gamete generation (GO:0043046) | 2.48493005 |
| 65 | cilium morphogenesis (GO:0060271) | 2.47175650 |
| 66 | regulation of cilium movement (GO:0003352) | 2.45682403 |
| 67 | rhodopsin mediated signaling pathway (GO:0016056) | 2.45084540 |
| 68 | protein polyglutamylation (GO:0018095) | 2.43391914 |
| 69 | cyclic nucleotide catabolic process (GO:0009214) | 2.42382865 |
| 70 | regulation of regulatory T cell differentiation (GO:0045589) | 2.42260867 |
| 71 | protein targeting to Golgi (GO:0000042) | 2.39947251 |
| 72 | embryonic epithelial tube formation (GO:0001838) | 2.39558529 |
| 73 | respiratory chain complex IV assembly (GO:0008535) | 2.39123484 |
| 74 | neuronal action potential (GO:0019228) | 2.39074550 |
| 75 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.38131473 |
| 76 | rRNA catabolic process (GO:0016075) | 2.38076536 |
| 77 | S-adenosylmethionine metabolic process (GO:0046500) | 2.37195309 |
| 78 | cilium organization (GO:0044782) | 2.34592420 |
| 79 | protein K63-linked deubiquitination (GO:0070536) | 2.34354592 |
| 80 | negative regulation of telomere maintenance (GO:0032205) | 2.33438721 |
| 81 | mannosylation (GO:0097502) | 2.33237278 |
| 82 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.31360226 |
| 83 | positive regulation of fatty acid transport (GO:2000193) | 2.29959551 |
| 84 | thyroid hormone metabolic process (GO:0042403) | 2.29922816 |
| 85 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.28197874 |
| 86 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.27334727 |
| 87 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.27305036 |
| 88 | cilium assembly (GO:0042384) | 2.26547274 |
| 89 | NAD biosynthetic process (GO:0009435) | 2.25934219 |
| 90 | cell wall macromolecule metabolic process (GO:0044036) | 2.25455384 |
| 91 | photoreceptor cell development (GO:0042461) | 2.24591182 |
| 92 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.24343752 |
| 93 | positive regulation of developmental pigmentation (GO:0048087) | 2.23412479 |
| 94 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.22797432 |
| 95 | regulation of action potential (GO:0098900) | 2.22689807 |
| 96 | keratinocyte development (GO:0003334) | 2.22203773 |
| 97 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.21228461 |
| 98 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.20378599 |
| 99 | protein K48-linked deubiquitination (GO:0071108) | 2.20245940 |
| 100 | regulation of acrosome reaction (GO:0060046) | 2.19869232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.97608551 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.80817362 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 2.77886537 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.67349596 |
| 5 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.50905724 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.44523570 |
| 7 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.38411798 |
| 8 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.33187830 |
| 9 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.16773588 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.14826454 |
| 11 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.12819351 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.12542863 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.11629382 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.00472043 |
| 15 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.00162372 |
| 16 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.99464915 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.95940051 |
| 18 | P300_19829295_ChIP-Seq_ESCs_Human | 1.92612242 |
| 19 | FUS_26573619_Chip-Seq_HEK293_Human | 1.86436146 |
| 20 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.85907023 |
| 21 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.83673279 |
| 22 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.83104948 |
| 23 | EWS_26573619_Chip-Seq_HEK293_Human | 1.82095645 |
| 24 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.79856955 |
| 25 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.77964478 |
| 26 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.72186492 |
| 27 | STAT3_23295773_ChIP-Seq_U87_Human | 1.59130471 |
| 28 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.55317286 |
| 29 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.54646785 |
| 30 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.53176087 |
| 31 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.52900670 |
| 32 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.52631946 |
| 33 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.51501557 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51110706 |
| 35 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.50357370 |
| 36 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.47877871 |
| 37 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.47846512 |
| 38 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.47099912 |
| 39 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.47099912 |
| 40 | AR_25329375_ChIP-Seq_VCAP_Human | 1.45824052 |
| 41 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44009442 |
| 42 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.43988069 |
| 43 | TCF4_23295773_ChIP-Seq_U87_Human | 1.43501778 |
| 44 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.41889662 |
| 45 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.40462746 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.39567504 |
| 47 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.35266871 |
| 48 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.33248769 |
| 49 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.33248769 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32773093 |
| 51 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32380422 |
| 52 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.32380422 |
| 53 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.32128242 |
| 54 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.31633928 |
| 55 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.31588310 |
| 56 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.30849525 |
| 57 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.30111302 |
| 58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29400663 |
| 59 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.28110572 |
| 60 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.26191755 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.25621411 |
| 62 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25611754 |
| 63 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.24683231 |
| 64 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.23174392 |
| 65 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.23174392 |
| 66 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20704281 |
| 67 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.20483409 |
| 68 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.20113749 |
| 69 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19700019 |
| 70 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.19113271 |
| 71 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.17696028 |
| 72 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.17489685 |
| 73 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16999452 |
| 74 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.16954344 |
| 75 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.16327868 |
| 76 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.16032813 |
| 77 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15237516 |
| 78 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.14765924 |
| 79 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.14403277 |
| 80 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13442904 |
| 81 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12140248 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10663325 |
| 83 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.10152828 |
| 84 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.09827547 |
| 85 | AR_20517297_ChIP-Seq_VCAP_Human | 1.08506758 |
| 86 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06552059 |
| 87 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06456832 |
| 88 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.06282551 |
| 89 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.06163380 |
| 90 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.05347663 |
| 91 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04572264 |
| 92 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04091346 |
| 93 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.02697397 |
| 94 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.02041097 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01549658 |
| 96 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.00619351 |
| 97 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00145078 |
| 98 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.00038074 |
| 99 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99882579 |
| 100 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.99285601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.29575943 |
| 2 | MP0003195_calcinosis | 3.69824589 |
| 3 | MP0008877_abnormal_DNA_methylation | 2.45919593 |
| 4 | MP0003787_abnormal_imprinting | 2.39818961 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 2.33981928 |
| 6 | MP0005551_abnormal_eye_electrophysiolog | 2.24750965 |
| 7 | MP0002102_abnormal_ear_morphology | 2.22754798 |
| 8 | MP0000372_irregular_coat_pigmentation | 2.12233826 |
| 9 | MP0001501_abnormal_sleep_pattern | 2.09411266 |
| 10 | MP0005174_abnormal_tail_pigmentation | 2.05642788 |
| 11 | MP0002876_abnormal_thyroid_physiology | 2.02297941 |
| 12 | MP0001986_abnormal_taste_sensitivity | 2.01678654 |
| 13 | MP0002638_abnormal_pupillary_reflex | 1.99928700 |
| 14 | MP0005671_abnormal_response_to | 1.96663071 |
| 15 | MP0001968_abnormal_touch/_nociception | 1.93621744 |
| 16 | MP0005075_abnormal_melanosome_morpholog | 1.89209023 |
| 17 | MP0006072_abnormal_retinal_apoptosis | 1.81583967 |
| 18 | MP0003646_muscle_fatigue | 1.78801159 |
| 19 | MP0009046_muscle_twitch | 1.78348507 |
| 20 | MP0000427_abnormal_hair_cycle | 1.66999108 |
| 21 | MP0005253_abnormal_eye_physiology | 1.66126758 |
| 22 | MP0005646_abnormal_pituitary_gland | 1.63083656 |
| 23 | MP0008872_abnormal_physiological_respon | 1.61871864 |
| 24 | MP0005645_abnormal_hypothalamus_physiol | 1.56278437 |
| 25 | MP0003136_yellow_coat_color | 1.54148939 |
| 26 | MP0003724_increased_susceptibility_to | 1.54068780 |
| 27 | MP0010386_abnormal_urinary_bladder | 1.51464722 |
| 28 | MP0009745_abnormal_behavioral_response | 1.51188601 |
| 29 | MP0002736_abnormal_nociception_after | 1.49437878 |
| 30 | MP0004142_abnormal_muscle_tone | 1.49391028 |
| 31 | MP0000015_abnormal_ear_pigmentation | 1.43648383 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.42642006 |
| 33 | MP0003011_delayed_dark_adaptation | 1.42386781 |
| 34 | MP0006276_abnormal_autonomic_nervous | 1.41390283 |
| 35 | MP0001485_abnormal_pinna_reflex | 1.39847354 |
| 36 | MP0004043_abnormal_pH_regulation | 1.37634098 |
| 37 | MP0002693_abnormal_pancreas_physiology | 1.32216188 |
| 38 | MP0004147_increased_porphyrin_level | 1.26828121 |
| 39 | MP0003950_abnormal_plasma_membrane | 1.26517046 |
| 40 | MP0003045_fibrosis | 1.25728003 |
| 41 | MP0002277_abnormal_respiratory_mucosa | 1.24469154 |
| 42 | MP0001800_abnormal_humoral_immune | 1.23293903 |
| 43 | MP0004381_abnormal_hair_follicle | 1.21543754 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.18565171 |
| 45 | MP0002272_abnormal_nervous_system | 1.15682286 |
| 46 | MP0008875_abnormal_xenobiotic_pharmacok | 1.15523947 |
| 47 | MP0002095_abnormal_skin_pigmentation | 1.11791053 |
| 48 | MP0002928_abnormal_bile_duct | 1.11458499 |
| 49 | MP0004130_abnormal_muscle_cell | 1.10873220 |
| 50 | MP0002653_abnormal_ependyma_morphology | 1.09205546 |
| 51 | MP0001486_abnormal_startle_reflex | 1.09002932 |
| 52 | MP0002938_white_spotting | 1.08499806 |
| 53 | MP0000230_abnormal_systemic_arterial | 1.06262952 |
| 54 | MP0001835_abnormal_antigen_presentation | 1.03966596 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 1.03434505 |
| 56 | MP0004885_abnormal_endolymph | 1.03220012 |
| 57 | MP0001984_abnormal_olfaction | 1.02621274 |
| 58 | MP0000383_abnormal_hair_follicle | 1.00713364 |
| 59 | MP0003763_abnormal_thymus_physiology | 1.00513224 |
| 60 | MP0009785_altered_susceptibility_to | 0.98964165 |
| 61 | MP0005389_reproductive_system_phenotype | 0.98701642 |
| 62 | MP0001970_abnormal_pain_threshold | 0.97884033 |
| 63 | MP0000631_abnormal_neuroendocrine_gland | 0.97266835 |
| 64 | MP0005171_absent_coat_pigmentation | 0.97015248 |
| 65 | MP0010329_abnormal_lipoprotein_level | 0.96714472 |
| 66 | MP0005310_abnormal_salivary_gland | 0.94802405 |
| 67 | MP0005386_behavior/neurological_phenoty | 0.93809927 |
| 68 | MP0004924_abnormal_behavior | 0.93809927 |
| 69 | MP0006054_spinal_hemorrhage | 0.93109170 |
| 70 | MP0002723_abnormal_immune_serum | 0.92638127 |
| 71 | MP0002168_other_aberrant_phenotype | 0.91659042 |
| 72 | MP0001873_stomach_inflammation | 0.91608444 |
| 73 | MP0005410_abnormal_fertilization | 0.89802903 |
| 74 | MP0008057_abnormal_DNA_replication | 0.89684511 |
| 75 | MP0002572_abnormal_emotion/affect_behav | 0.88868951 |
| 76 | MP0002163_abnormal_gland_morphology | 0.88836468 |
| 77 | MP0003137_abnormal_impulse_conducting | 0.88633547 |
| 78 | MP0002733_abnormal_thermal_nociception | 0.88448962 |
| 79 | MP0000685_abnormal_immune_system | 0.87299322 |
| 80 | MP0001905_abnormal_dopamine_level | 0.87159797 |
| 81 | MP0002148_abnormal_hypersensitivity_rea | 0.85953994 |
| 82 | MP0002064_seizures | 0.85345499 |
| 83 | MP0008995_early_reproductive_senescence | 0.84375207 |
| 84 | MP0005000_abnormal_immune_tolerance | 0.83838206 |
| 85 | MP0002420_abnormal_adaptive_immunity | 0.82759112 |
| 86 | MP0001919_abnormal_reproductive_system | 0.81692526 |
| 87 | MP0001944_abnormal_pancreas_morphology | 0.81065023 |
| 88 | MP0009764_decreased_sensitivity_to | 0.80548109 |
| 89 | MP0002254_reproductive_system_inflammat | 0.80155715 |
| 90 | MP0001790_abnormal_immune_system | 0.79892376 |
| 91 | MP0005387_immune_system_phenotype | 0.79892376 |
| 92 | MP0001819_abnormal_immune_cell | 0.79848986 |
| 93 | MP0002009_preneoplasia | 0.77452229 |
| 94 | MP0002160_abnormal_reproductive_system | 0.76857049 |
| 95 | MP0008961_abnormal_basal_metabolism | 0.76593200 |
| 96 | MP0001765_abnormal_ion_homeostasis | 0.76306137 |
| 97 | MP0002452_abnormal_antigen_presenting | 0.76041999 |
| 98 | MP0005379_endocrine/exocrine_gland_phen | 0.76038343 |
| 99 | MP0002067_abnormal_sensory_capabilities | 0.75561796 |
| 100 | MP0003252_abnormal_bile_duct | 0.74743298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pancreatic cysts (HP:0001737) | 4.80391828 |
| 2 | Pancreatic fibrosis (HP:0100732) | 4.10848416 |
| 3 | Abnormality of midbrain morphology (HP:0002418) | 3.90031502 |
| 4 | Molar tooth sign on MRI (HP:0002419) | 3.90031502 |
| 5 | True hermaphroditism (HP:0010459) | 3.80185782 |
| 6 | Congenital stationary night blindness (HP:0007642) | 3.72883681 |
| 7 | Abnormality of the renal cortex (HP:0011035) | 3.64555060 |
| 8 | Nephronophthisis (HP:0000090) | 3.40747415 |
| 9 | Hyperventilation (HP:0002883) | 3.36937092 |
| 10 | Attenuation of retinal blood vessels (HP:0007843) | 3.26581495 |
| 11 | Abnormality of the renal medulla (HP:0100957) | 3.13061995 |
| 12 | Gaze-evoked nystagmus (HP:0000640) | 3.12162735 |
| 13 | Progressive inability to walk (HP:0002505) | 3.03982830 |
| 14 | Medial flaring of the eyebrow (HP:0010747) | 2.96740170 |
| 15 | Polydipsia (HP:0001959) | 2.96134158 |
| 16 | Abnormal drinking behavior (HP:0030082) | 2.96134158 |
| 17 | Cystic liver disease (HP:0006706) | 2.91800845 |
| 18 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.82844882 |
| 19 | Tubular atrophy (HP:0000092) | 2.81788721 |
| 20 | Stomatitis (HP:0010280) | 2.80839571 |
| 21 | Abolished electroretinogram (ERG) (HP:0000550) | 2.80404167 |
| 22 | Large for gestational age (HP:0001520) | 2.80252398 |
| 23 | Inability to walk (HP:0002540) | 2.78221620 |
| 24 | Renal cortical cysts (HP:0000803) | 2.75727767 |
| 25 | Stomach cancer (HP:0012126) | 2.69706808 |
| 26 | Genetic anticipation (HP:0003743) | 2.66623355 |
| 27 | Type II lissencephaly (HP:0007260) | 2.62606799 |
| 28 | Hypothermia (HP:0002045) | 2.59768342 |
| 29 | Fair hair (HP:0002286) | 2.52784046 |
| 30 | Chronic hepatic failure (HP:0100626) | 2.52336244 |
| 31 | Progressive cerebellar ataxia (HP:0002073) | 2.46105121 |
| 32 | Hypoproteinemia (HP:0003075) | 2.43608151 |
| 33 | Congenital, generalized hypertrichosis (HP:0004540) | 2.40729110 |
| 34 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.38900970 |
| 35 | Decreased circulating renin level (HP:0003351) | 2.36576775 |
| 36 | Thyroiditis (HP:0100646) | 2.36525167 |
| 37 | Furrowed tongue (HP:0000221) | 2.30735290 |
| 38 | Decreased central vision (HP:0007663) | 2.25948061 |
| 39 | Generalized hypopigmentation of hair (HP:0011358) | 2.25560729 |
| 40 | Congenital primary aphakia (HP:0007707) | 2.17791069 |
| 41 | Gait imbalance (HP:0002141) | 2.17694603 |
| 42 | Tetany (HP:0001281) | 2.17353703 |
| 43 | Constricted visual fields (HP:0001133) | 2.16239477 |
| 44 | Polyuria (HP:0000103) | 2.16083733 |
| 45 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.15195197 |
| 46 | Abnormality of alanine metabolism (HP:0010916) | 2.15195197 |
| 47 | Hyperalaninemia (HP:0003348) | 2.15195197 |
| 48 | Abnormal biliary tract physiology (HP:0012439) | 2.15007658 |
| 49 | Bile duct proliferation (HP:0001408) | 2.15007658 |
| 50 | Abnormality of T cell number (HP:0011839) | 2.13178085 |
| 51 | Absent/shortened dynein arms (HP:0200106) | 2.12540536 |
| 52 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.12540536 |
| 53 | Male pseudohermaphroditism (HP:0000037) | 2.12293844 |
| 54 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.11276981 |
| 55 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.11203147 |
| 56 | Clumsiness (HP:0002312) | 2.10039472 |
| 57 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.09959851 |
| 58 | Keratoconus (HP:0000563) | 2.09678845 |
| 59 | Increased corneal curvature (HP:0100692) | 2.09678845 |
| 60 | Nephrogenic diabetes insipidus (HP:0009806) | 2.09523145 |
| 61 | Congenital hepatic fibrosis (HP:0002612) | 2.08969477 |
| 62 | Absent speech (HP:0001344) | 2.06298757 |
| 63 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.06256445 |
| 64 | Congenital sensorineural hearing impairment (HP:0008527) | 2.05885831 |
| 65 | Cerebellar dysplasia (HP:0007033) | 2.05718656 |
| 66 | IgG deficiency (HP:0004315) | 2.05262442 |
| 67 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.04609967 |
| 68 | Sclerocornea (HP:0000647) | 1.99817064 |
| 69 | Widely spaced teeth (HP:0000687) | 1.97163245 |
| 70 | Intestinal atresia (HP:0011100) | 1.95674479 |
| 71 | Anencephaly (HP:0002323) | 1.93942711 |
| 72 | Hypomagnesemia (HP:0002917) | 1.93600114 |
| 73 | Facial diplegia (HP:0001349) | 1.92978985 |
| 74 | T lymphocytopenia (HP:0005403) | 1.92319898 |
| 75 | Broad-based gait (HP:0002136) | 1.92036069 |
| 76 | Lissencephaly (HP:0001339) | 1.87280887 |
| 77 | Severe combined immunodeficiency (HP:0004430) | 1.86762924 |
| 78 | Protruding tongue (HP:0010808) | 1.86154655 |
| 79 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.85553020 |
| 80 | Genital tract atresia (HP:0001827) | 1.85317467 |
| 81 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.85144925 |
| 82 | Ketoacidosis (HP:0001993) | 1.84536657 |
| 83 | Abnormal albumin level (HP:0012116) | 1.80044689 |
| 84 | Hypoalbuminemia (HP:0003073) | 1.80044689 |
| 85 | Concave nail (HP:0001598) | 1.79654147 |
| 86 | Optic neuritis (HP:0100653) | 1.79626802 |
| 87 | Retrobulbar optic neuritis (HP:0100654) | 1.79626802 |
| 88 | Abnormality of B cell number (HP:0010975) | 1.78225396 |
| 89 | Hemiparesis (HP:0001269) | 1.76749489 |
| 90 | Abnormal ciliary motility (HP:0012262) | 1.76606769 |
| 91 | Vaginal atresia (HP:0000148) | 1.76365692 |
| 92 | Febrile seizures (HP:0002373) | 1.73780247 |
| 93 | Ketosis (HP:0001946) | 1.72897161 |
| 94 | Postaxial foot polydactyly (HP:0001830) | 1.72263999 |
| 95 | Abnormality of renin-angiotensin system (HP:0000847) | 1.71100250 |
| 96 | Abnormality of the pons (HP:0007361) | 1.70021959 |
| 97 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.69585203 |
| 98 | Abnormality of eosinophils (HP:0001879) | 1.68919500 |
| 99 | Abnormality of T cells (HP:0002843) | 1.67914585 |
| 100 | Nephrotic syndrome (HP:0000100) | 1.67795335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 7.26499000 |
| 2 | BMPR1B | 3.46535050 |
| 3 | TXK | 2.95953944 |
| 4 | ADRBK2 | 2.83635969 |
| 5 | TAOK3 | 2.74100263 |
| 6 | ACVR1B | 2.62985061 |
| 7 | GRK1 | 2.40708638 |
| 8 | ZAK | 2.18481271 |
| 9 | MAP4K2 | 2.16498106 |
| 10 | WNK3 | 1.93177277 |
| 11 | NUAK1 | 1.90974530 |
| 12 | PINK1 | 1.80617652 |
| 13 | TLK1 | 1.61698391 |
| 14 | MAPK13 | 1.52083914 |
| 15 | INSRR | 1.51800473 |
| 16 | OXSR1 | 1.49529449 |
| 17 | TEC | 1.47850295 |
| 18 | WNK4 | 1.43789871 |
| 19 | MST4 | 1.33098491 |
| 20 | STK39 | 1.30622154 |
| 21 | STK38L | 1.26235579 |
| 22 | ADRBK1 | 1.20292881 |
| 23 | PAK3 | 1.17907976 |
| 24 | PIK3CG | 1.15825150 |
| 25 | ITK | 1.14221593 |
| 26 | NLK | 1.13987660 |
| 27 | CAMKK2 | 1.12751092 |
| 28 | TNK2 | 1.10655155 |
| 29 | TRIM28 | 1.07611124 |
| 30 | TGFBR1 | 1.07053918 |
| 31 | MAP3K4 | 1.02443965 |
| 32 | PTK2B | 0.96301064 |
| 33 | IKBKB | 0.95277159 |
| 34 | PRKCQ | 0.94809594 |
| 35 | DAPK2 | 0.91301701 |
| 36 | SYK | 0.89530319 |
| 37 | TRPM7 | 0.89473096 |
| 38 | MKNK2 | 0.87836445 |
| 39 | PIK3CA | 0.87125676 |
| 40 | FGFR2 | 0.85817396 |
| 41 | NTRK3 | 0.85736799 |
| 42 | PRKCE | 0.85300229 |
| 43 | GRK6 | 0.83809293 |
| 44 | MAPK15 | 0.83078553 |
| 45 | KIT | 0.83063896 |
| 46 | CASK | 0.82592417 |
| 47 | MARK3 | 0.81978643 |
| 48 | MAPKAPK3 | 0.79951930 |
| 49 | PDK2 | 0.78542211 |
| 50 | IKBKE | 0.77028678 |
| 51 | FES | 0.75720177 |
| 52 | MAP4K1 | 0.75124250 |
| 53 | CSNK1G1 | 0.73988511 |
| 54 | PRKCG | 0.69607092 |
| 55 | BTK | 0.68817899 |
| 56 | STK3 | 0.67717846 |
| 57 | TNIK | 0.66474055 |
| 58 | CSNK1G2 | 0.66285308 |
| 59 | LCK | 0.65335437 |
| 60 | IRAK1 | 0.64847917 |
| 61 | MAP2K6 | 0.63085233 |
| 62 | CSNK1G3 | 0.62649314 |
| 63 | MUSK | 0.61487784 |
| 64 | LATS1 | 0.60182888 |
| 65 | ERBB3 | 0.59835395 |
| 66 | AKT3 | 0.59321464 |
| 67 | GRK7 | 0.58269725 |
| 68 | PLK2 | 0.56277930 |
| 69 | MAP3K12 | 0.56179322 |
| 70 | BRSK2 | 0.55212445 |
| 71 | LYN | 0.52722354 |
| 72 | PHKG2 | 0.51161413 |
| 73 | PHKG1 | 0.51161413 |
| 74 | EPHA3 | 0.51010925 |
| 75 | VRK1 | 0.48143387 |
| 76 | SGK2 | 0.47978941 |
| 77 | STK38 | 0.47933340 |
| 78 | RPS6KA5 | 0.45386804 |
| 79 | STK11 | 0.45043465 |
| 80 | BCKDK | 0.45021819 |
| 81 | PRKAA2 | 0.44000423 |
| 82 | CHUK | 0.41505160 |
| 83 | FER | 0.40047890 |
| 84 | CAMK1 | 0.39190145 |
| 85 | CSNK1A1L | 0.39007379 |
| 86 | CAMK2A | 0.38792818 |
| 87 | SIK2 | 0.38630879 |
| 88 | HCK | 0.38449965 |
| 89 | ABL1 | 0.38314374 |
| 90 | CSNK1A1 | 0.37910717 |
| 91 | PRKACA | 0.37141980 |
| 92 | MAP2K1 | 0.36831458 |
| 93 | CSNK1D | 0.36267269 |
| 94 | SIK3 | 0.35430622 |
| 95 | PRKCH | 0.34049305 |
| 96 | BMPR2 | 0.33971905 |
| 97 | PRKCA | 0.32860540 |
| 98 | IGF1R | 0.32497284 |
| 99 | TIE1 | 0.32004892 |
| 100 | MAPKAPK5 | 0.31759521 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.82469442 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 2.80646388 |
| 3 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.67004543 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.24981643 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.24973864 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.21645088 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10749484 |
| 8 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.02527944 |
| 9 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.92513541 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.83374641 |
| 11 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.78417377 |
| 12 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.75976133 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.75512601 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.74589802 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.60484840 |
| 16 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.53911531 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.53300192 |
| 18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.51876811 |
| 19 | Nicotine addiction_Homo sapiens_hsa05033 | 1.50988640 |
| 20 | * Nitrogen metabolism_Homo sapiens_hsa00910 | 1.48364755 |
| 21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46003326 |
| 22 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.38407459 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.35936078 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.32696046 |
| 25 | ABC transporters_Homo sapiens_hsa02010 | 1.31597393 |
| 26 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.31486931 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.29557640 |
| 28 | Homologous recombination_Homo sapiens_hsa03440 | 1.29302038 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.26944535 |
| 30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.26073932 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.22574008 |
| 32 | Circadian rhythm_Homo sapiens_hsa04710 | 1.22411737 |
| 33 | Morphine addiction_Homo sapiens_hsa05032 | 1.20519040 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.19987592 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.19839244 |
| 36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.17161396 |
| 37 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.16799021 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12194193 |
| 39 | Protein export_Homo sapiens_hsa03060 | 1.12146216 |
| 40 | Asthma_Homo sapiens_hsa05310 | 1.11987314 |
| 41 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.11842494 |
| 42 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.11727938 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.09948129 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06452775 |
| 45 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.05158398 |
| 46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04442159 |
| 47 | Insulin secretion_Homo sapiens_hsa04911 | 1.01881198 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.01471745 |
| 49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.01080532 |
| 50 | Basal transcription factors_Homo sapiens_hsa03022 | 1.01061145 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 0.99425257 |
| 52 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.97885476 |
| 53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.96835561 |
| 54 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.96304161 |
| 55 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.96176822 |
| 56 | Salivary secretion_Homo sapiens_hsa04970 | 0.95248924 |
| 57 | RNA polymerase_Homo sapiens_hsa03020 | 0.90440991 |
| 58 | Circadian entrainment_Homo sapiens_hsa04713 | 0.88820939 |
| 59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84351568 |
| 60 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.82020381 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81899416 |
| 62 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.81380577 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79811688 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77560995 |
| 65 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.77195488 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76756850 |
| 67 | RNA degradation_Homo sapiens_hsa03018 | 0.76219666 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75587223 |
| 69 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.73655705 |
| 70 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73635652 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73603651 |
| 72 | Histidine metabolism_Homo sapiens_hsa00340 | 0.73279589 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 0.72224339 |
| 74 | GABAergic synapse_Homo sapiens_hsa04727 | 0.68406283 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67403460 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.67248533 |
| 77 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66987682 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66194470 |
| 79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64607739 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.62710682 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62547064 |
| 82 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.60760908 |
| 83 | Renin secretion_Homo sapiens_hsa04924 | 0.58942033 |
| 84 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.58606390 |
| 85 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.56454607 |
| 86 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.55969590 |
| 87 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.53011885 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.52613493 |
| 89 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47767712 |
| 90 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47008751 |
| 91 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.46869946 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46814769 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46452363 |
| 94 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.44968431 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44034443 |
| 96 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43871333 |
| 97 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.43486780 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41935249 |
| 99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.41475330 |
| 100 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.41010150 |

